New Advances in Chemical Research, May 2021. Application In Synthesis of (S)-4-Phenylthiazolidine-2-thione, Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction by binding to a specific portion of an enzyme and thus slowing or preventing a reaction from occurring. In a document type is Article, and a compound is mentioned, 185137-29-5, (S)-4-Phenylthiazolidine-2-thione, introducing its new discovery.
We recently reported a new C3-symmetric (R)-phenylglycinol N-1,3,5-benzenetricarboxylic acid-derived chiral high-performance liquid chromatography (HPLC) stationary phase (CSP 1) that demonstrated better results as compared to a previously described N-3,5-dintrobenzoyl (DNB) (R)-phenylglycinol-derived CSP. Over a decade ago, (S)-leucinol, (R)-phenylglycine, and (S)-leucine derivatives were used as the starting materials of 3,5-DNB-based Pirkle-type CSPs for chiral separation. In this study, three new C3-symmetric CSPs (CSP 2, 3, and 4) were prepared by combining the ideas and results mentioned above. Here we describe the synthetic procedures and applications of the new C3-symmetric CSPs (CSP 2?CSP 4).
One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Application In Synthesis of (S)-4-Phenylthiazolidine-2-thione, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 185137-29-5
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H785N | ChemSpider